Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-2-26
pubmed:abstractText
Islet transplantation is limited by islet graft failure because of poor revascularization, host immune rejection, and nonspecific inflammatory response. Human vascular endothelial growth factor (hVEGF) gene delivery is likely to promote islet revascularization and survival.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0724-8741
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15-25
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:14984253-Animals, pubmed-meshheading:14984253-Cells, Cultured, pubmed-meshheading:14984253-Drug Delivery Systems, pubmed-meshheading:14984253-Gene Therapy, pubmed-meshheading:14984253-Genetic Vectors, pubmed-meshheading:14984253-Humans, pubmed-meshheading:14984253-Islets of Langerhans, pubmed-meshheading:14984253-Islets of Langerhans Transplantation, pubmed-meshheading:14984253-Jurkat Cells, pubmed-meshheading:14984253-Kidney Cortex, pubmed-meshheading:14984253-Male, pubmed-meshheading:14984253-Mice, pubmed-meshheading:14984253-Mice, Inbred NOD, pubmed-meshheading:14984253-Mice, SCID, pubmed-meshheading:14984253-Neovascularization, Physiologic, pubmed-meshheading:14984253-Rats, pubmed-meshheading:14984253-Transfection, pubmed-meshheading:14984253-Vascular Endothelial Growth Factor A
pubmed:year
2004
pubmed:articleTitle
Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets.
pubmed:affiliation
Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 26 South Dunlap Street, Feurt Building RM 406, Memphis, Tennessee 38163, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't